Literature DB >> 2972603

Interleukin-2 production and response by helper T-cell subsets in man.

M Salmon1, G D Kitas, J S Gaston, P A Bacon.   

Abstract

This study investigated the production of, and response to, the lymphokine interleukin-2 (IL-2) by functional subsets of human CD4+ T lymphocytes. Fresh peripheral blood mononuclear cells (PBMC) were sorted into CD4+2H4+/4B4- suppressor-inducer cells, and CD4+2H4-/4B4+ helper cells. The suppressor-inducer subset proliferated well in response to the T-cell mitogens concanavalin A (Con) A and phytohaemagglutinin (PHA), and produced IL-2. The helper cells produced no detectable IL-2 and proliferated poorly. However, the latter population were induced to express functional IL-2 receptors by Con A or purified protein derivative (PPD), and proliferated well if supplied with exogenous rIL-2. These findings suggest that the two functional CD4 subsets are not independent, or counteracting, but rather that the generation of T-cell help is likely to involve cooperative interactions between the two subsets.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972603      PMCID: PMC1385023     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

3.  Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues.

Authors:  A Wang; S D Lu; D F Mark
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

4.  Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction.

Authors:  P L Romain; C Morimoto; J F Daley; L S Palley; E L Reinherz; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1984-01

5.  Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

6.  The dissociation of interleukin-2 production and antigen-specific helper activity by clonal analysis.

Authors:  J R Lamb; E D Zanders; M Feldmann; P Lake; D D Eckels; J N Woody; P C Beverley
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

7.  Frequency and surface phenotype of human T lymphocytes producing interleukin 2. Analysis by limiting dilution and cell cloning.

Authors:  A Moretta
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

8.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

Authors:  M Linker-Israeli; A C Bakke; R C Kitridou; S Gendler; S Gillis; D A Horwitz
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.

Authors:  T A Luger; J S Smolen; T M Chused; A D Steinberg; J J Oppenheim
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

View more
  9 in total

1.  Concomitant augmentation of CD4+ CD45R+ suppressor/inducer subset and diminution of CD4+ CDw29+ helper/inducer subset during rush hyposensitization in hymenoptera venom allergy.

Authors:  L Tilmant; J P Dessaint; A Tsicopoulos; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

2.  Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

Authors:  I Jokinen; K Poikonen; T Möttönen; P Hannonen; M Oka; J Ilonen; H M Surcel; R Karttunen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

3.  Synovial T lymphocyte recognition of organisms that trigger reactive arthritis.

Authors:  J S Gaston; P F Life; K Granfors; R Merilahti-Palo; L Bailey; S Consalvey; A Toivanen; P A Bacon
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  Synovial fluid antigen-presenting cells unmask peripheral blood T cell responses to bacterial antigens in inflammatory arthritis.

Authors:  P F Life; N J Viner; P A Bacon; J S Gaston
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

5.  The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.

Authors:  S Poppema
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

6.  The effect of anti-CD4 on helper function of CD4,45RA+ versus CD4,45RO+ T cells.

Authors:  J Wang; T Yan; B Simmer; F Emmrich
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

7.  Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo.

Authors:  E W Nijhuis; E J Remarque; B Hinloopen; T Van der Pouw-Kraan; R A Van Lier; G J Ligthart; L Nagelkerken
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

8.  A novel X-linked combined immunodeficiency disease.

Authors:  E G Brooks; F C Schmalstieg; D P Wirt; H M Rosenblatt; L T Adkins; D P Lookingbill; H E Rudloff; T A Rakusan; A S Goldman
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

9.  Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 4. Effects of multiple-dose treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus).

Authors:  R Neubert; G Golor; R Stahlmann; H Helge; D Neubert
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.